Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001096906-11-001025
Filing Date
2011-05-23
Accepted
2011-05-23 12:13:20
Documents
1
Period of Report
2008-06-28

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 5003
  Complete submission text file 0001096906-11-001025.txt   6709
Mailing Address 15 EXCHANGE PLACE, SUITE 500 JERSEY CITY NJ 07302
Business Address 15 EXCHANGE PLACE, SUITE 500 JERSEY CITY NJ 07302 646-367-1747
AOXING PHARMACEUTICAL COMPANY, INC. (Issuer) CIK: 0001060426 (see all company filings)

EIN.: 650636168 | State of Incorp.: FL | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address NO.1 INDUSTRY DISTRICT XINLE CITY HEBEI PROVINCE F4 050700
Business Address
Yue Zhenjiang (Reporting) CIK: 0001360531 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32674 | Film No.: 11864076